Skip to content

The effect of high-flow therapy by nasal cannulae on early postoperative hypoxemia after single-lung ventilation thoracoscopic surgery and the incidence of pulmonary complications 7 days after surgery: a multi-center prospective randomized controlled study

The effect of high-flow therapy by nasal cannulae on early postoperative hypoxemia after single-lung ventilation thoracoscopic surgery and the incidence of pulmonary complications 7 days after surgery: a multi-center prospective randomized controlled study

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100042488
Enrollment
Unknown
Registered
2021-01-22
Start date
2021-02-01
Completion date
Unknown
Last updated
2021-04-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung Disease

Interventions

Traditional nasal low flow oxygen inhalation group:transnasal low-flow therapy by nasal cannulae

Sponsors

Shenzhen Second People's Hospital / The First Affiliated Hospital of Shenzhen University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. Patients aged from 18 to 60 years old are going to receive wedge resection or lobectomy under thoracoscope under one lung ventilation; 2. Patients with one lung ventilation more than 1 hour during operation; 3. Informed and voluntary patients participated in this study and signed informed consent.

Exclusion criteria

Exclusion criteria: 1. Subjects with body mass index >= 30 kg / m2; 2. Patients with pulmonary infection before operation; 3. Subjects with nasal diseases who could not use nasal ventilation; 4. Subjects whose pulse oxygen saturation of air breathing is less than 96%; 5. Subjects with left lung surgery or estimated surgical range more than one lobe; 6. Patients with respiratory failure or adult respiratory distress syndrome before operation; 7. Patients with obstructive sleep apnea before operation; 8. Subjects with long-term smoking history (smoking more than one cigarette a day and continuously smoking for more than 6 months); 9. Patients with severe liver and kidney diseases (child Pugh grade C or preoperative dialysis patients); Albumin < 35g / L; 10. Subjects with preoperative cardiac function grade 3 or above; 11. Patients with history of abusing narcotic sedatives and analgesics; There are contraindications or allergies to the test drug and other narcotic drugs.

Design outcomes

Primary

MeasureTime frame
The incidence of hypoxemia;

Secondary

MeasureTime frame
VAS;Breathing discomfort score;Ratio of patients needing continued respiratory support treatment;Rates of patients requiring endotracheal intubation or non-invasive ventilator treatment;Rates of pulmonary complication;Rates of patients who were transferred to ICU unplanned;Hospitalization days;In-hospital mortality;

Countries

China

Contacts

Public ContactZhao Zhao

Shenzhen Second People's Hospital / The First Affiliated Hospital of Shenzhen University

34756257@qq.com+86 13421325490

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026